EC Number   |
Title |
Organism |
|---|
   1.3.1.118 | A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
| 1.3.1.118 | A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis |
Mycobacterium tuberculosis ATCC 25618 |
| 1.3.1.118 | An overview on crystal structures of InhA protein Apo-form, in complex with its natural ligands and inhibitors |
Mycobacterium tuberculosis |
| 1.3.1.118 | An overview on crystal structures of InhA protein Apo-form, in complex with its natural ligands and inhibitors |
Mycobacterium tuberculosis ATCC 25618 |
| 1.3.1.118 | Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex A molecular dynamics simulation study |
Mycobacterium tuberculosis |
| 1.3.1.118 | Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex A molecular dynamics simulation study |
Mycobacterium tuberculosis ATCC 25618 |
| 1.3.1.118 | Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate |
Mycobacterium tuberculosis |
| 1.3.1.118 | Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate |
Mycobacterium tuberculosis ATCC 25618 |
| 1.3.1.118 | Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis |
Mycobacterium tuberculosis |
| 1.3.1.118 | Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis |
Mycobacterium tuberculosis ATCC 25618 |
